Inflammatory Bowel Disease Market Growing Adoption Accelerated by Increasing Prevalence
Inflammatory Bowel Disease Market Inflammatory bowel disease (IBD) refers to chronic conditions of the colon and small intestine namely Crohn's disease and ulcerative colitis. Products used in the treatment of IBD help control symptoms, promote remission, and prevent disease flares. Drugs such as aminosalicylates, immunosuppressants, corticosteroids and biologics are commonly used to treat IBD. The global Inflammatory Bowel Disease Market is estimated to be valued at US$ 21.5 billion in 2023 and is expected to exhibit a CAGR of 4.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The increasing prevalence of IBD has accelerated the growing adoption of various treatment options. The rising prevalence of IBD worldwide can be attributed to changing lifestyle patterns, increasing consumption of processed and junk foods, growing pollution levels etc. According to CCF, over 10 million people suffer from IBD